We are live on
!
Find out more
IVP
Intrinsic Value Partners Portfolio holdings
AUM
$146M
1-Year Est. Return
37.26%
This Fund
S&P 500
This Quarter
Est. Return
-20.16%
1 Year Est. Return
+37.26%
3 Year Est. Return
+125.97%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$78.4M
AUM Growth
-$16M
(-17%)
Cap. Flow
+$4.29M
Cap. Flow
% of AUM
5.47%
Top 10 Holdings %
Top 10 Hldgs %
58.9%
Holding
55
New
7
Increased
6
Reduced
33
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$1.45M |
| 2 |
ASML
ASML
|
+$930K |
| 3 |
Intercontinental Exchange
ICE
|
+$708K |
| 4 |
Snowflake
SNOW
|
+$681K |
| 5 |
Pinterest
PINS
|
+$658K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enovis
ENOV
|
+$317K |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$244K |
| 3 |
Fastenal
FAST
|
+$231K |
| 4 |
Bausch Health
BHC
|
+$226K |
| 5 |
Citigroup
C
|
+$145K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 38.03% |
| 2 | Communication Services | 18% |
| 3 | Technology | 12.07% |
| 4 | Consumer Discretionary | 8.33% |
| 5 | Industrials | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
W.W. Grainger
GWW
$65.9B
| $203K | 0.26% |
446
| – | – |
|
52
Cyclerion Therapeutics
CYCN
$15.8M
| $27K | 0.03% |
2,416
-80
| -3% | -$1.15K |
|
|
CIH
53
DELISTED
China Index Holdings Limited American Depository Shares
CIH
| $11K | 0.01% |
15,700
-5,430
| -26% | -$4.7K |
|
|
54
Bausch Health
BHC
$1.8B
| – | – |
-9,873
| Closed | -$226K |
|
|
55
Fastenal
FAST
$52.2B
| – | – |
-7,778
| Closed | -$231K |
|
Similar funds
G
SWM
CC
BFM
AC
WFS
SFSG
SCA
Intrinsic Value Partners's Q2 2022 Portfolio in Review
As of Q2 2022, Intrinsic Value Partners held 55 positions worth $78.4M, down 17% from $94.4M the previous quarter. Its ten largest holdings account for 59% of the portfolio.
Intrinsic Value Partners deployed $4.29M of net new capital in Q2 2022, opening 7 new positions and adding to 6 existing holdings. Its largest new stake was Moderna: 10,135 shares worth $1.45M.
By sector, the portfolio is most concentrated in Financials at 38% of assets, down from 40% a quarter earlier, followed by Communication Services and Technology.
On the sell side, the largest reduction was Enovis, an estimated $317K trimmed.
- Intrinsic Value Partners's largest Q2 2022 buy was Moderna: 10,135 shares worth $1.45M.
- Intrinsic Value Partners added most to Peloton Interactive in Q2 2022, an estimated $445K increase.
- Intrinsic Value Partners's biggest Q2 2022 reduction was Enovis, cutting an estimated $317K.
- Intrinsic Value Partners fully exited Fastenal in Q2 2022, selling an estimated $231K.
- Intrinsic Value Partners's ten largest holdings make up 59% of its $78.4M portfolio in Q2 2022.
- Intrinsic Value Partners opened 7 new positions and closed 2 in Q2 2022.
- Intrinsic Value Partners's portfolio value fell 17% quarter-over-quarter to $78.4M.
Based on Intrinsic Value Partners's 13F filing for Q2 2022, filed 18 Jul 2022.